(Q44827323)

6 December 2017

FHIT mRNA and protein expression in hepatocellular carcinoma (English)

1 reference

6 December 2017

6

Michael Torbenson

1 reference

6 December 2017

Rajesh Kannangai

1

1 reference

6 December 2017

Fikret Sahin

2

1 reference

6 December 2017

Onikepe Adegbola

3

1 reference

6 December 2017

Raheela Ashfaq

4

1 reference

6 December 2017

Gloria H Su

5

1 reference

6 December 2017

1 June 2004

1 reference

6 December 2017

1 reference

6 December 2017

17

1 reference

6 December 2017

653-659

1 reference

6 December 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1038/modpathol.3800102

6 December 2017

0 references

cites work

The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

The tumor spectrum in FHIT-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Variable FHIT transcripts in non-neoplastic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Aberrant FHIT transcripts in hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Different gene expression of MDM2, GAGE-1, -2 and FHIT in hepatocellular carcinoma and focal nodular hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Expression of vascular endothelial growth factor-C in benign and malignant thyroid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Hepatic adenomas: analysis of sex steroid receptor status and the Wnt signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

FHIT: from gene discovery to cancer treatment and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

FHIT expression in clear cell renal carcinomas: versatility of protein levels and correlation with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Analysis of the FHIT gene and its product in squamous cell carcinomas of the head and neck

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Loss of fragile histidine triad protein in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

inferred from DOI database lookup

7 January 2021

based on heuristic

Smad4 overexpression in hepatocellular carcinoma is strongly associated with transforming growth factor beta II receptor immunolabeling

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800102

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/MODPATHOL.3800102

1 reference

6 December 2017

1 reference